SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-028908
Filing Date
2020-10-21
Accepted
2020-10-21 17:00:27
Documents
2
Period of Report
2020-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1676
2 EX-24 DOCUMENT attachment1.htm EX-24 3959
  Complete submission text file 0000899243-20-028908.txt   7068
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Ege David S. (Reporting) CIK: 0001829360 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 201251006